REFERENCES
- Adamus G, Machnicki M, Elerding H, Sugden B, Blocker Y S, Fox D A. Antibodies to recoverin induced apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmunity 1998; 11: 523–33, [CSA]
- American Academy of Ophthalmology. Intraocular Inflammation and Uveitis. Basic and Clinical Science Course. 2004; 86–89
- Arnold A C, Lee A G. Systemic disease and neuro-ophthalmology: annual update 2000. J Neuroophthalmology 2001; 21: 46–61, [CSA]
- Chan J W. Paraneoplastic retinopathies and optic neuropathies. Survey Ophthalmology 2003; 48: 12–38, [CSA], [CROSSREF]
- Foster C S, Vitale A T. Diagnosis and Treatment of Uveitis. W.B. Saunders, Philadelphia, PA 2002; 520–527
- Gass JDM. Neoplastic Diseases of the Retina and Optic Disc; Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, Ed 4. Mosby, St. Louis 1997; 894–896
- Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin. Arch Ophthalmology 1999; 127: 612–4, [CSA], [CROSSREF]
- Hooks J J, Tso M O, Detrick B. Retinopathies associated with anti-retinal antibodies. Clinical and Diagnostic Laboratory Immunology Sept., 2001; 853–58, [CSA], [CROSSREF]
- Jacobson D M, Thirkill C E, Tipping S J. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 1990; 28: 162–7, [INFOTRIEVE], [CSA], [CROSSREF]
- Keltner J L, Roth A M, Chang R S. Photoreceptor degeneration. Possible auto-immune disorder. Arch Ophthalmology 1983; 101: 564–69, [CSA]
- Keltner J L, Thirkill C E. Cancer-associated retinopathy vs. recoverin-associated retinopathy. Am J Ophthalmology 1998; 126: 296–302, [CSA], [CROSSREF]
- Ling C PW, Pavesio C. Paraneoplastic syndromes associated with visual loss. Current Opinion in Ophthalmology 2003; 14: 426–32, [INFOTRIEVE], [CSA], [CROSSREF]
- Maeda T, Maeda A, Maruyama I, Ogawa K, Kuroki Y, Sahara H, Sato N, Ohguro H. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Investigative Ophthalmology & Visual Science March, 2001; 42(3)705–12, [INFOTRIEVE], [CSA]
- McGinnis J F, Austin B, Klisk I, Heinzmann C, Kojis T, Saprkes R S. Chromosomal assignment of the human gene for the cancer-associated retinopathy protein to chromosome 17p13.1. J Neuroscience Research 1995; 40: 165–8, [CSA], [CROSSREF]
- Ohguro H, Ogawa K, Maeda T, Maeda A, Maruyama I. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Investigative Ophthalmology & Research in Vision and Ophthalmology Dec., 1999; 40(13)3160–67, [INFOTRIEVE], [CSA]
- Posner J B. Immunology of paraneoplastic syndromes: Overview. Ann N Y Acad Sci 2003; 998: 178–86, [INFOTRIEVE], [CSA], [CROSSREF]
- Sawyer R A, Selhorst J B, Zimmerman L E, et al. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmology 1976; 181: 606–13, [CSA]
- Solomon S D, Smith J H, O'Brien J. Ocular manifestation of systemic malignancies. Current Opinion in Ophthalmology 1999; 10: 447–51, [INFOTRIEVE], [CSA]
- Thirkill C E, Roth A M, Keltner J L. Cancer-associated retinopathy. Arch Ophthalmology 1987; 105: 372–75, [CSA]
- Thirkill C E, Tait R C, Tyler N K. The Cancer-Associated Retinopathy antigen is a recoverin-like protein. Invest Ophthalmology Vis Sci 1992; 33: 2768–72, [CSA]
- Whitcup S M, Vistica B P, Milam A H, Nussenblatt R B, Gary I. Recoverin-associated retinopathy: a clinical and immunologically distinctive disease. Am J Ophthalmology 1998; 126: 230–7, [CSA], [CROSSREF]